Cargando…

Large and small cribriform architecture have similar adverse clinical outcome on prostate cancer biopsies

AIMS: Invasive cribriform and intraductal carcinoma (IDC) are associated with adverse outcome in prostate cancer patients, with the large cribriform pattern having the worst outcome in radical prostatectomies. Our objective was to determine the impact of the large and small cribriform patterns in pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rijstenberg, L Lucia, Hansum, Tim, Kweldam, Charlotte F, Kümmerlin, Intan P, Remmers, Sebastiaan, Roobol, Monique J, van Leenders, Geert J L H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321809/ https://www.ncbi.nlm.nih.gov/pubmed/35384019 http://dx.doi.org/10.1111/his.14658

Ejemplares similares

Updating the Rotterdam Prostate Cancer Risk Calculator with Invasive Cribriform and/or Intraductal Carcinoma for Men with a Prior Negative Biopsy
por: Remmers, Sebastiaan, et al.
Publicado: (2021)

Intraductal carcinoma has a minimal impact on Grade Group assignment in prostate cancer biopsy and radical prostatectomy specimens
por: Rijstenberg, L. Lucia, et al.
Publicado: (2020)

On cribriform prostate cancer
por: Kweldam, Charlotte F., et al.
Publicado: (2018)

Concordance of cribriform architecture in matched prostate cancer biopsy and radical prostatectomy specimens
por: Hollemans, Eva, et al.
Publicado: (2019)

Automated detection of cribriform growth patterns in prostate histology images
por: Ambrosini, Pierre, et al.
Publicado: (2020)

Clinical outcome comparison of Grade Group 1 and Grade Group 2 prostate cancer with and without cribriform architecture at the time of radical prostatectomy
por: Hollemans, Eva, et al.
Publicado: (2020)

Cribriform architecture in radical prostatectomies predicts oncological outcome in Gleason score 8 prostate cancer patients
por: Hollemans, Eva, et al.
Publicado: (2020)

Percentage Gleason pattern 4 and PI-RADS score predict upgrading in biopsy Grade Group 2 prostate cancer patients without cribriform pattern
por: van der Slot, Margaretha A., et al.
Publicado: (2022)

Large cribriform growth pattern identifies ISUP grade 2 prostate cancer at high risk for recurrence and metastasis
por: Hollemans, Eva, et al.
Publicado: (2018)

Alternative prostate cancer grading systems incorporating percent pattern 4/5 (IQ-Gleason) and cribriform architecture (cGrade) improve prediction of outcome after radical prostatectomy
por: Seyrek, Neslisah, et al.
Publicado: (2022)

Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterations
por: Böttcher, René, et al.
Publicado: (2018)

Cribriform architecture outperforms Gleason pattern 4 percentage and tertiary Gleason pattern 5 in predicting the outcome of Grade Group 2 prostate cancer patients
por: Seyrek, Neslisah, et al.
Publicado: (2021)

Prognostic Histopathological and Molecular Markers on Prostate Cancer Needle-Biopsies: A Review
por: Hoogland, A. Marije, et al.
Publicado: (2014)

Equivocal PI-RADS Three Lesions on Prostate Magnetic Resonance Imaging: Risk Stratification Strategies to Avoid MRI-Targeted Biopsies
por: Osses, Daniël F., et al.
Publicado: (2020)

Personalized strategies in population screening for prostate cancer
por: Remmers, Sebastiaan, et al.
Publicado: (2020)

Reduction of MRI-targeted biopsies in men with low-risk prostate cancer on active surveillance by stratifying to PI-RADS and PSA-density, with different thresholds for significant disease
por: Schoots, Ivo G., et al.
Publicado: (2018)

Inter-observer variability of cribriform architecture and percent Gleason pattern 4 in prostate cancer: relation to clinical outcome
por: van der Slot, Margaretha A., et al.
Publicado: (2020)

Reducing prostate biopsies and magnetic resonance imaging with prostate cancer risk stratification
por: Davik, Petter, et al.
Publicado: (2022)

The Patient Journey from Randomization to Detection of Prostate Cancer and Death: Results from ERSPC Rotterdam
por: Remmers, Sebastiaan, et al.
Publicado: (2023)

Reducing Biopsies and Magnetic Resonance Imaging Scans During the Diagnostic Pathway of Prostate Cancer: Applying the Rotterdam Prostate Cancer Risk Calculator to the PRECISION Trial Data
por: Remmers, Sebastiaan, et al.
Publicado: (2021)

Cribriform ulcerations of the back
por: Aivaz, Marudeen, et al.
Publicado: (2020)

NeuroSAFE in radical prostatectomy increases the rate of nerve‐sparing surgery without affecting oncological outcome
por: van der Slot, Margaretha A., et al.
Publicado: (2022)

Automated Reconstruction Algorithm for Identification of 3D Architectures of Cribriform Ductal Carcinoma In Situ
por: Norton, Kerri-Ann, et al.
Publicado: (2012)

Progressive cribriform and zosteriform hyperpigmentation
por: Gutte, Rameshwar M.
Publicado: (2014)

A literature review to understand health literacy in men with prostate cancer on active surveillance
por: Beyer, Katharina, et al.
Publicado: (2023)

Prostate cancer upgrading with serial prostate magnetic resonance imaging and repeat biopsy in men on active surveillance: are confirmatory biopsies still necessary?
por: Osses, Daniël F., et al.
Publicado: (2020)

Predicting biochemical recurrence and prostate cancer‐specific mortality after radical prostatectomy: comparison of six prediction models in a cohort of patients with screening‐ and clinically detected prostate cancer
por: Remmers, Sebastiaan, et al.
Publicado: (2019)

Comedonecrosis Gleason pattern 5 is associated with worse clinical outcome in operated prostate cancer patients
por: Hansum, Tim, et al.
Publicado: (2021)

Primary Cutaneous Cribriform Apocrine Carcinoma
por: Boettler, Michelle, et al.
Publicado: (2021)

Cribriform-morular variant of thyroid carcinoma
por: Cameselle-Teijeiro, J.M., et al.
Publicado: (2019)

Cribriform pattern in prostate tissues: Predictor for intraductal carcinoma of the prostate based on biopsy and radical prostatectomy pathology
por: Shiomi, Ei, et al.
Publicado: (2022)

Post‐radiotherapy cribriform‐morular thyroid carcinoma
por: Or Koca, Arzu, et al.
Publicado: (2022)

Detailed Evaluation of Androgen Deprivation Overtreatment in Prostate Cancer Patients Compared to the European Association of Urology Guidelines Using Long-term Data from the European Randomised Study of Screening for Prostate Cancer Rotterdam
por: Hogenhout, Renée, et al.
Publicado: (2022)

Comparison of clinically significant prostate cancer detection by MRI cognitive biopsy and in-bore MRI-targeted biopsy for naïve biopsy patients
por: Zhang, Kai, et al.
Publicado: (2020)

Diagnostic performance of a nomogram incorporating cribriform morphology for the prediction of adverse pathology in prostate cancer at radical prostatectomy
por: Wang, Baojun, et al.
Publicado: (2020)

Zymogen and activated protein C have similar structural architecture
por: Stojanovski, Bosko M., et al.
Publicado: (2020)

Progressive cribriform and zosteriform hyperpigmentation: Where are we at present?
por: Goyal, Tarang
Publicado: (2013)

A rare case of breast invasive cribriform carcinoma
por: Tuan, Ho Xuan, et al.
Publicado: (2023)

Cribriform carcinoma arising in a benign phyllodes tumor
por: Shaaya, Elia Shazniza, et al.
Publicado: (2023)

Distinct Adverse Clinical Outcomes of Small and Large Cribriform Patterns on Gleason 7 Prostate Cancer: A Preliminary Study
por: Kazan, Ozgur, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gpo5nvpimp625jk12qfvl33jcj